about
Osteoclasts are active in bone forming metastases of prostate cancer patientsActivation of the RalGEF/Ral pathway promotes prostate cancer metastasis to boneMolecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerAge-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progressionA microRNA code for prostate cancer metastasis.The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasisA novel 3-D mineralized tumor model to study breast cancer bone metastasisCombined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathwaysLow-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new boneThe role of PTEN in prostate cancer cell tropism to the bone micro-environment.Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process.Gene targeting to the stroma of the prostate and bone.Study of matrix metalloproteinases and their inhibitors in prostate cancer.Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft modelSelf-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity.Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts.Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and ProgressionMolecular genetics of prostate cancer: new prospects for old challengesComputational identification of surrogate genes for prostate cancer phases using machine learning and molecular network analysis.Novel therapies for metastatic castrate-resistant prostate cancer.Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer.Targeting the osteosarcoma cancer stem cellIn vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors.Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit.Probing the interaction forces of prostate cancer cells with collagen I and bone marrow derived stem cells on the single cell level.Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.p21CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1.The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancerHeme oxygenase-1 (HO-1) expression in prostate cancer cells modulates the oxidative response in bone cells.Bone resorption facilitates osteoblastic bone metastatic colonization by cooperation of insulin-like growth factor and hypoxia.CCL2 is a potent regulator of prostate cancer cell migration and proliferation.Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironmentModuleRole: a tool for modulization, role determination and visualization in protein-protein interaction networksSelection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors.Imaging active urokinase plasminogen activator in prostate cancer.Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches
P2860
Q21090081-632D7F39-71C5-45CF-8799-BA5F60FC5546Q24681479-7F3F7879-E8A3-4247-BBA1-7D44572DCAD8Q27024775-5909D2A5-B155-407A-96EF-750F4CFDB56EQ27027373-5BE3BAD2-06A8-4B04-BDEF-61ACBBA3DAEDQ27310006-DF9A25CC-615F-4CFC-B5A4-A1BC508911B2Q27437809-D6832F5F-7B33-4C85-8C0A-C104F7398DEEQ28472598-24CB2077-B3C9-4270-B422-0D9D4AD462B7Q28484572-4DC0970F-256C-478C-8F91-76BF9BFC4B87Q28593008-455BDB99-CE37-46D3-BC05-5DC3D3240C59Q30443138-4D0ADFF4-C7C6-4CD4-AABA-6C22CDB38296Q30482634-7E5C6558-4887-4F26-9971-15C57B8C536FQ33281964-66F615D4-78FF-40E1-A0FB-C200E4DB7376Q33699188-0479016C-21BC-4381-BA4A-43FE299D7EF6Q33708162-3E72CB83-18DF-4C99-83B8-EC66563AFEF1Q33823691-C2828513-717A-4789-A5AB-C8AD76CC03B6Q33850663-3A78AC1D-127E-43DE-8593-AD4909E4DE6AQ34056013-4CEB587B-1BC2-49CF-A6F3-8FC6E491C04EQ34067118-1A3BD246-E03D-456D-9993-4CC6DF55EEF6Q34090617-14A6A493-52BF-48BA-ACB6-419139CAD2E9Q34127462-718E286A-3DC9-453E-8E27-B77F5B0F748FQ34155176-31626F76-11C6-417F-AF63-06B4CF20C9EFQ34249263-9835AC39-B075-4721-950D-AC023859810AQ34309227-D6CC4C36-6447-4847-B6CC-C2E34F562C33Q34335524-51E9CCA3-FB84-4B75-8A93-7213B8653318Q34368788-C4C2ACDD-9802-417A-BD3B-30BC53EFDD8FQ34417941-45FC030D-C7D3-4C5A-9A70-C271AF5139D5Q34614433-DB95A2E4-0569-4C79-8FFB-E516D3A61655Q34664057-1C73450E-836A-4284-8E82-E8A045B2C03EQ34685574-BBC35CE4-CD31-4A8B-B731-72E0B439D70DQ34699785-D609D535-5C24-43EB-9E42-D30DBFDDB8CBQ34999463-B4C05A68-9A14-4EBC-B873-8D1EC5323A2FQ35041634-E29A3141-9974-4BF8-BCE8-293BE10C7FCCQ35051528-ADCB99B0-8C92-47B5-8035-70BA8E603481Q35082684-776FE31B-EB80-48DB-9FD5-159038EDF4D3Q35148340-CB8DFDD2-9902-4A1F-92CC-DA7963BB6659Q35161718-BA30A76B-5BDB-48FA-A9F1-025AC9B02171Q35229487-CA6F0948-0725-4F99-B34D-0E664107C445Q35251858-8C59DCA5-628D-4C8F-BDB3-18BDF147AAD9Q35287094-95C00072-EDCD-4450-BCD3-94FDF7392D7AQ35499809-E2689688-CF8D-464B-AFDE-FD428076AE1C
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Osteoblasts in prostate cancer metastasis to bone.
@ast
Osteoblasts in prostate cancer metastasis to bone.
@en
type
label
Osteoblasts in prostate cancer metastasis to bone.
@ast
Osteoblasts in prostate cancer metastasis to bone.
@en
prefLabel
Osteoblasts in prostate cancer metastasis to bone.
@ast
Osteoblasts in prostate cancer metastasis to bone.
@en
P2860
P356
P1476
Osteoblasts in prostate cancer metastasis to bone.
@en
P2093
Christopher J Logothetis
Sue-Hwa Lin
P2860
P2888
P356
10.1038/NRC1528
P407
P577
2005-01-01T00:00:00Z